CSL Behring N.V., a global leader in biotherapeutics, is headquartered in Belgium and operates extensively across Europe, North America, and Asia-Pacific. Founded in 1904, the company has established itself in the biotechnology industry, focusing on the development and manufacture of innovative therapies for rare and serious medical conditions. CSL Behring is renowned for its core products, including immunoglobulins, clotting factors, and albumin, which are derived from human plasma. These therapies are unique due to their high purity and efficacy, addressing critical health needs for patients with immune deficiencies and bleeding disorders. With a strong market position, CSL Behring has achieved significant milestones, including numerous regulatory approvals and a commitment to advancing patient care through research and development.
We don't have data for CSL Behring N.V., but we can show you information about their parent organization instead.
View parent company